Memantine benefits functional abilities in moderate to severe Alzheimer’s disease

被引：0
|
作者：
Bengt Winblad
S. Gauthier
D. Åström
K. Stender
机构：
[1] Alzheimer Disease Research Center (KI-ADRC) NOVUM,Karolinska Institutet
[2] Douglas Institute for Mental Health,McGill Center for Studies in Aging
[3] H. Lundbeck A/S,Karolinska Institutet
[4] Alzheimer Disease Research Center (KI-ADRC) NOVUM,undefined
来源：
The journal of nutrition, health & aging | 2010年 / 14卷
关键词：
Memantine; Alzheimer’s disease; functional ability;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：770 / 774
页数：4
相关论文
共 50 条
  • [21] Benefits of combined cholinesterase inhibitor and memantine treatment in moderate-severe Alzheimer's disease
    Gauthier, Serge
    Molinuevo, Jose L.
    ALZHEIMERS & DEMENTIA, 2013, 9 (03) : 326 - 331
  • [22] Specific functional effects of memantine treatment in patients with moderate to severe Alzheimer's disease
    Doody, R
    Wirth, Y
    Schmitt, F
    Möbius, HJ
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 18 (02) : 227 - 232
  • [23] Memantine therapy in patients with moderate to severe Alzheimer's disease
    Ochudlo, S
    Targosz, M
    Liberska, A
    Opala, G
    INTERNATIONAL PSYCHOGERIATRICS, 2005, 17 : 235 - 235
  • [24] Management of moderate to severe Alzheimer's disease: Focus on memantine
    Dominguez, Evangelyn
    Chin, Ting-Yu
    Chen, Chih-Ping
    Wu, Tzong-Yuan
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2011, 50 (04): : 415 - 423
  • [25] Overview of memantine data in moderate to severe Alzheimer's disease
    Wilkinson, David
    NEUROBIOLOGY OF AGING, 2008, 29 : S25 - S26
  • [26] Responders to memantine treatment in moderate to severe Alzheimer's disease
    Stöffler, A
    Ferris, SH
    Wirth, Y
    Reisberg, B
    NEUROBIOLOGY OF AGING, 2004, 25 : S212 - S212
  • [27] Memantine in moderate-to-severe Alzheimer's disease - Reply
    Reisberg, B
    Doody, R
    Mobius, HJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06): : 610 - 610
  • [28] Memantine improves independence in moderate to severe Alzheimer's disease
    Guilhaume, C
    Lundbeck, H
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S207 - S208
  • [29] Memantine approved to treat moderate to severe Alzheimer’s disease
    Karen Marder
    Current Neurology and Neuroscience Reports, 2004, 4 (5) : 349 - 350
  • [30] Memantine enhances autonomy in moderate to severe Alzheimer's disease
    Rive, B
    Vercelletto, M
    Damier, FD
    Cochran, J
    François, C
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2004, 19 (05) : 458 - 464
12345